Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to able to join this trial:
- People who have been diagnosed with Parkinson's disease
- People whose Parkinson's disease is rated as stage 1, 2, or 3 on a standard scale that measures how much the condition affects daily movement and balance (Hoehn & Yahr stages 1–3)
- People whose Parkinson's medications have stayed the same for at least 4 weeks
- People who score 18 or higher on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA)
- People who are able to walk on their own, whether or not they use a walking aid such as a cane or walker
- People whose doctor has confirmed they are medically safe to take part in moderate-intensity exercise
Who may not be able to join:
- People who have recently had a change in their Parkinson's medications
- People for whom exercise is medically inadvisable or unsafe for any reason (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Raphael M Ritti-Dias, PhD, University of Nove de Julho
Phone: +5519999406878
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Cerebrovascular Reactivity; Change in Neurovascular Coupling at 12 Weeks.; Change in Dynamic Cerebral Autoregulation; Change in Acute Cerebral Blood Flow Response to Exercise
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.